| Year |
Citation |
Score |
| 2011 |
Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, Chen Y, Modiri AN, Judge DP, Dietz HC. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science (New York, N.Y.). 332: 361-5. PMID 21493863 DOI: 10.1126/Science.1192152 |
0.591 |
|
| 2011 |
Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, et al. Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science (New York, N.Y.). 332: 358-61. PMID 21493862 DOI: 10.1126/Science.1192149 |
0.565 |
|
| 2010 |
Renard M, Holm T, Veith R, Callewaert BL, Adès LC, Baspinar O, Pickart A, Dasouki M, Hoyer J, Rauch A, Trapane P, Earing MG, Coucke PJ, Sakai LY, Dietz HC, et al. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. European Journal of Human Genetics : Ejhg. 18: 895-901. PMID 20389311 DOI: 10.1038/Ejhg.2010.45 |
0.603 |
|
| 2010 |
Matt P, Huso DL, Habashi J, Holm T, Doyle J, Schoenhoff F, Liu G, Black J, Van Eyk JE, Dietz HC. Murine model of surgically induced acute aortic dissection type A. The Journal of Thoracic and Cardiovascular Surgery. 139: 1041-7. PMID 19910001 DOI: 10.1016/J.Jtcvs.2009.08.039 |
0.502 |
|
| 2009 |
Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, Loeys B, Huso DL, McDonnell NB, Van Eyk JE, Dietz HC, et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation. 120: 526-32. PMID 19635970 DOI: 10.1161/Circulationaha.108.841981 |
0.582 |
|
| 2007 |
Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nature Medicine. 13: 204-10. PMID 17237794 DOI: 10.1038/Nm1536 |
0.592 |
|
| 2007 |
Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Erratum: Corrigendum: Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states Nature Medicine. 13: 511-511. DOI: 10.1038/Nm0407-511A |
0.511 |
|
| 2006 |
Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. The New England Journal of Medicine. 355: 788-98. PMID 16928994 DOI: 10.1056/Nejmoa055695 |
0.642 |
|
| 2006 |
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (New York, N.Y.). 312: 117-21. PMID 16601194 DOI: 10.1126/Science.1124287 |
0.641 |
|
| 2006 |
Loeys B, Schwarze L, Holm T. Aneurysm Syndromes Caused By Mutations In The TGF-Beta Receptor Journal of Vascular Surgery. 44: 1374-1375. DOI: 10.1016/J.Jvs.2006.10.011 |
0.533 |
|
| 2005 |
Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nature Genetics. 37: 275-81. PMID 15731757 DOI: 10.1038/Ng1511 |
0.634 |
|
| Show low-probability matches. |